Takeda, Iambic Launch Up-to-$1.7B AI Collaboration
Takeda Pharmaceutical will apply Iambic Therapeutics’ artificial intelligence (AI)-based technologies and wet lab capabilities to design and develop small molecule...
Takeda Pharmaceutical will apply Iambic Therapeutics’ artificial intelligence (AI)-based technologies and wet lab capabilities to design and develop small molecule...
Nabla Bio announced a new multi-year research collaboration with Takeda aiming to advance AI-driven design of protein therapeutics. This collaboration...